Right ventricular failure after left ventricular assist device (LVAD) implantation is associated
with high mortality. Management remains limited to pharmacologic therapy and temporary
mechanical support. Delayed right ventricular assist device (RVAD) support after LVAD
implantation is associated with poorer outcomes. With the advent of miniaturized, durable,
continuous flow ventricular assist device systems, chronic RVAD and biventricular assist
device (BiVAD) support has been used with some success. The purpose of this study was to …

Purpose Right ventricular failure post LVAD implantation is associated with high mortality.
Management remains limited to pharmacological therapy and temporary mechanical
support. Delayed RVAD support post LVAD implantation is associated with poor outcomes.
However, with the advent of miniaturised, durable, continuous flow BiVAD and RVAD
system, delayed RVAD support with these devices may overcome existing limitations of
current treatment alternative. To test this hypothesis, a mock circulatory loop was developed …